Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 1.680
-0.075 (-4.27%)
At close: Jun 11, 2025
Bio-Works Technologies AB Revenue
Bio-Works Technologies AB had revenue of 9.09M SEK in the quarter ending March 31, 2025, a decrease of -39.63%. This brings the company's revenue in the last twelve months to 32.82M, down -17.17% year-over-year. In the year 2024, Bio-Works Technologies AB had annual revenue of 30.49M, down -30.55%.
Revenue (ttm)
32.82M
Revenue Growth
-17.17%
P/S Ratio
4.25
Revenue / Employee
1.13M
Employees
30
Market Cap
139.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.49M | -13.41M | -30.55% |
| Dec 31, 2023 | 43.90M | 2.58M | 6.23% |
| Dec 31, 2022 | 41.32M | -15.04M | -26.68% |
| Dec 31, 2021 | 56.36M | 49.13M | 679.08% |
| Dec 31, 2020 | 7.23M | 1.66M | 29.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |